BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 22820288)

  • 1. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver.
    Hsu SH; Wang B; Kota J; Yu J; Costinean S; Kutay H; Yu L; Bai S; La Perle K; Chivukula RR; Mao H; Wei M; Clark KR; Mendell JR; Caligiuri MA; Jacob ST; Mendell JT; Ghoshal K
    J Clin Invest; 2012 Aug; 122(8):2871-83. PubMed ID: 22820288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis.
    Tsai WC; Hsu SD; Hsu CS; Lai TC; Chen SJ; Shen R; Huang Y; Chen HC; Lee CH; Tsai TF; Hsu MT; Wu JC; Huang HD; Shiao MS; Hsiao M; Tsou AP
    J Clin Invest; 2012 Aug; 122(8):2884-97. PubMed ID: 22820290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3.
    Wei L; Chiu DK; Tsang FH; Law CT; Cheng CL; Au SL; Lee JM; Wong CC; Ng IO; Wong CM
    J Hepatol; 2017 Oct; 67(4):758-769. PubMed ID: 28532996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma.
    El Tayebi HM; Hosny KA; Esmat G; Breuhahn K; Abdelaziz AI
    FEBS Lett; 2012 Sep; 586(19):3309-16. PubMed ID: 22819824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM24 suppresses development of spontaneous hepatic lipid accumulation and hepatocellular carcinoma in mice.
    Jiang S; Minter LC; Stratton SA; Yang P; Abbas HA; Akdemir ZC; Pant V; Post S; Gagea M; Lee RG; Lozano G; Barton MC
    J Hepatol; 2015 Feb; 62(2):371-9. PubMed ID: 25281858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-122 is a unique molecule with great potential in diagnosis, prognosis of liver disease, and therapy both as miRNA mimic and antimir.
    Thakral S; Ghoshal K
    Curr Gene Ther; 2015; 15(2):142-50. PubMed ID: 25537773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
    Quan H; Li B; Yang J
    Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA.
    Cui M; Wang Y; Sun B; Xiao Z; Ye L; Zhang X
    Biochem Biophys Res Commun; 2014 Feb; 444(2):270-5. PubMed ID: 24462768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin.
    Wang X; Chen J; Li F; Lin Y; Zhang X; Lv Z; Jiang J
    Biochem Biophys Res Commun; 2012 Nov; 428(4):525-31. PubMed ID: 23068095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of circular RNA circ_001569 indicates poor prognosis in hepatocellular carcinoma and promotes cell growth and metastasis by sponging miR-411-5p and miR-432-5p.
    Liu H; Xue L; Song C; Liu F; Jiang T; Yang X
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2659-2665. PubMed ID: 30086881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct anti-oncogenic effect of various microRNAs in different mouse models of liver cancer.
    Tao J; Ji J; Li X; Ding N; Wu H; Liu Y; Wang XW; Calvisi DF; Song G; Chen X
    Oncotarget; 2015 Mar; 6(9):6977-88. PubMed ID: 25762642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis.
    Xu X; Fan Z; Kang L; Han J; Jiang C; Zheng X; Zhu Z; Jiao H; Lin J; Jiang K; Ding L; Zhang H; Cheng L; Fu H; Song Y; Jiang Y; Liu J; Wang R; Du N; Ye Q
    J Clin Invest; 2013 Feb; 123(2):630-45. PubMed ID: 23321675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma.
    Liu S; Guo W; Shi J; Li N; Yu X; Xue J; Fu X; Chu K; Lu C; Zhao J; Xie D; Wu M; Cheng S; Liu S
    J Hepatol; 2012 Feb; 56(2):389-96. PubMed ID: 21888875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma.
    Li D; Liu X; Lin L; Hou J; Li N; Wang C; Wang P; Zhang Q; Zhang P; Zhou W; Wang Z; Ding G; Zhuang SM; Zheng L; Tao W; Cao X
    J Biol Chem; 2011 Oct; 286(42):36677-85. PubMed ID: 21878637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
    Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA-93-5p promotes hepatocellular carcinoma progression via a microRNA-93-5p/MAP3K2/c-Jun positive feedback circuit.
    Shi X; Liu TT; Yu XN; Balakrishnan A; Zhu HR; Guo HY; Zhang GC; Bilegsaikhan E; Sun JL; Song GQ; Weng SQ; Dong L; Ott M; Zhu JM; Shen XZ
    Oncogene; 2020 Aug; 39(35):5768-5781. PubMed ID: 32719439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-501-3p suppresses metastasis and progression of hepatocellular carcinoma through targeting LIN7A.
    Luo C; Yin D; Zhan H; Borjigin U; Li C; Zhou Z; Hu Z; Wang P; Sun Q; Fan J; Zhou J; Wang X; Zhou S; Huang X
    Cell Death Dis; 2018 May; 9(5):535. PubMed ID: 29749382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor.
    Hsu SH; Yu B; Wang X; Lu Y; Schmidt CR; Lee RJ; Lee LJ; Jacob ST; Ghoshal K
    Nanomedicine; 2013 Nov; 9(8):1169-80. PubMed ID: 23727126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1.
    Wang YG; Wang T; Shi M; Zhai B
    J Exp Clin Cancer Res; 2019 Apr; 38(1):153. PubMed ID: 30971290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.